We are live on ! Find out more
Corriente Advisors

Corriente Advisors Portfolio holdings

AUM $9.5M Turnover 83.33%
1-Year Est. Return 805.26%
This Fund
S&P 500
This Quarter Est. Return
+77.69%
1 Year Est. Return
+805.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
–
Cap. Flow
+$160M
Cap. Flow %
86.04%
Top 10 Hldgs %
91.77%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.43%
2 Technology 22.58%
3 Industrials 14.96%
4 Communication Services 7.33%
5 Materials 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MAXR
1
DELISTED
Maxar Technologies
MAXR
$42M 22.58%
+2,682,790
New +$27.9M
2019 Q4
0 quarters
RETA
2
DELISTED
Reata Pharmaceuticals
RETA
$39.3M 21.08%
+192,000
New +$35M
2019 Q4
0 quarters
SPCE icon
3
Virgin Galactic
SPCE
$158M
$27.9M 14.96%
+120,586
New +$23.5M
2019 Q4
0 quarters
QURE icon
4
uniQure
QURE
$1.36B
$18.1M 9.72%
+252,500
New +$13.9M
2019 Q4
0 quarters
TPTX
5
DELISTED
Turning Point Therapeutics
TPTX
$17.8M 9.54%
+285,000
New +$13.6M
2019 Q4
0 quarters
I
6
DELISTED
Intelsat
I
$11.5M 6.16%
+1,631,227
New +$25.6M
2019 Q4
0 quarters
CUE icon
7
Cue Biopharma
CUE
$34.7M
$4.52M 2.43%
+9,500
New +$2.98M
2019 Q4
0 quarters
ATXS icon
8
DELISTED
Astria Therapeutics
ATXS
$3.65M 1.96%
+102,847
New +$3.24M
2019 Q4
0 quarters
GBT
9
DELISTED
Global Blood Therapeutics
GBT
$3.18M 1.71%
+40,000
New +$2.37M
2019 Q4
0 quarters
EIGR
10
DELISTED
Eiger BioPharmaceuticals
EIGR
$3.04M 1.63%
+6,797
New +$2.41M
2019 Q4
0 quarters
SPCE.WS icon
11
CALL
DELISTED
Virgin Galactic Holdings Warrants
SPCE.WS
$2.92M 1.57%
+252,983
New +$607K
2019 Q4
0 quarters
APTO
12
DELISTED
Aptose Biosciences
APTO
$2.57M 1.38%
+1,007
New +$1.31M
2019 Q4
0 quarters
EQX icon
13
Equinox Gold
EQX
$10B
$2.31M 1.24%
+300,000
New +$1.86M
2019 Q4
0 quarters
DIS icon
14
Walt Disney
DIS
$202B
$2.17M 1.17%
+15,000
New +$2.09M
2019 Q4
0 quarters
RCKT icon
15
Rocket Pharmaceuticals
RCKT
$218M
$2.02M 1.09%
+88,927
New +$1.49M
2019 Q4
0 quarters
BLU
16
DELISTED
BELLUS Health
BLU
$1.67M 0.9%
+220,000
New +$1.5M
2019 Q4
0 quarters
GFI icon
17
Gold Fields
GFI
$27.9B
$1.65M 0.89%
+250,000
New +$1.42M
2019 Q4
0 quarters

Similar funds

Corriente Advisors's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Corriente Advisors, which disclosed 17 positions worth $186M. Its ten largest holdings account for 92% of the portfolio.

Its largest position is Reata Pharmaceuticals: 192,000 shares worth $39.3M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Technology and Industrials.

  • Corriente Advisors's largest Q4 2019 buy was Reata Pharmaceuticals: 192,000 shares worth $39.3M.
  • Corriente Advisors's ten largest holdings make up 92% of its $186M portfolio in Q4 2019.
  • Corriente Advisors disclosed 17 positions in Q4 2019, its first 13F filing on record.

Based on Corriente Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.